Macular Degeneration

Another landmark moment in eye care occurred this year with the approval of pegcetacoplan, known as Syfovre from Apellis Pharmaceuticals, allowing treatment for the geographic atrophy form of macular degeneration.

Writer’s block is not really a common thing for me, but I do have to admit that there are times when I just sit, stare at my laptop, and hope that some sort of inspiration will drive my fingers across the keyboard.

Healio spoke with Yasha Modi, MD, about biomarkers that can help predict a patient's risk for developing geographic atrophy.

Longer acting anti-VEGF therapies that require fewer injections and clinic visits may provide greater cost-saving benefit for patients with age-related macular degeneration, according to a study in Clinical Ophthalmology.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Calvin W. Roberts, MD, discusses a new understanding in the way patients with macular degeneration see.

With emerging treatment options and technological advances that make detection and monitoring more precise, timely and easier, wet age-related macular degeneration continues to be a vibrant area of research and innovation.

NEW YORK — A retrospective study of more than 36,000 patients showed that geographic atrophy causes substantial disease burden, according to a speaker here.

NEW YORK — In this Healio Video Perspective from the ASRS meeting, Arshad Khanani, MD, MA, FASRS, discusses the efficacy of dual inhibition with faricimab in treating patients with neovascular age-related macular degeneration.

NEW YORK — Ellipsoid zone integrity is a major driver of visual acuity outcomes in eyes with neovascular age-related macular degeneration without intraretinal fluid.

NEW YORK — Some groups of patients, including women and smokers, have higher rates of conversion from nonexudative to exudative age-related macular degeneration in their fellow eye, according to a study.